VIRDIS, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 18.477
AS - Asia 6.453
EU - Europa 5.791
SA - Sud America 1.070
AF - Africa 285
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 32.096
Nazione #
US - Stati Uniti d'America 18.004
CN - Cina 2.177
IT - Italia 1.714
SG - Singapore 1.582
HK - Hong Kong 1.402
BR - Brasile 965
SE - Svezia 918
DE - Germania 768
BG - Bulgaria 657
TR - Turchia 452
CA - Canada 414
GB - Regno Unito 370
RU - Federazione Russa 350
FI - Finlandia 307
VN - Vietnam 275
UA - Ucraina 271
IN - India 162
CI - Costa d'Avorio 138
FR - Francia 101
CH - Svizzera 99
KR - Corea 70
BD - Bangladesh 47
BE - Belgio 46
JP - Giappone 46
AT - Austria 38
IQ - Iraq 37
PK - Pakistan 33
AR - Argentina 27
NL - Olanda 27
SN - Senegal 27
ES - Italia 25
ZA - Sudafrica 25
UZ - Uzbekistan 24
MX - Messico 22
SA - Arabia Saudita 21
PL - Polonia 20
VE - Venezuela 17
BJ - Benin 16
CO - Colombia 16
GR - Grecia 15
NG - Nigeria 15
MA - Marocco 14
EC - Ecuador 13
IL - Israele 13
IE - Irlanda 12
JM - Giamaica 11
PY - Paraguay 11
AU - Australia 10
JO - Giordania 10
KE - Kenya 10
TN - Tunisia 10
DZ - Algeria 9
ID - Indonesia 9
AE - Emirati Arabi Uniti 8
EG - Egitto 7
OM - Oman 7
RO - Romania 7
UY - Uruguay 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
KG - Kirghizistan 6
LB - Libano 6
NP - Nepal 6
CL - Cile 5
EU - Europa 5
HR - Croazia 5
HU - Ungheria 5
KZ - Kazakistan 5
MY - Malesia 5
PH - Filippine 5
PS - Palestinian Territory 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AL - Albania 4
AZ - Azerbaigian 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
KH - Cambogia 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PE - Perù 4
RS - Serbia 4
AM - Armenia 3
BN - Brunei Darussalam 3
BO - Bolivia 3
DK - Danimarca 3
ET - Etiopia 3
GH - Ghana 3
LK - Sri Lanka 3
TJ - Tagikistan 3
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
Totale 32.068
Città #
Woodbridge 2.391
Houston 1.731
Fairfield 1.713
Ashburn 1.707
Ann Arbor 1.687
Hong Kong 1.384
Chandler 1.093
Santa Clara 984
Singapore 850
Seattle 736
Sofia 656
Shanghai 642
Wilmington 590
Cambridge 569
Beijing 478
Serra 478
New York 420
Ottawa 366
Milan 354
Jacksonville 338
Boardman 323
Princeton 292
Izmir 275
Lawrence 272
Medford 240
Nanjing 227
Munich 197
Des Moines 172
Istanbul 145
Abidjan 138
Hefei 127
Los Angeles 126
Florence 110
Nanchang 106
San Diego 99
Dong Ket 98
Frankfurt am Main 97
Dearborn 89
Lancaster 88
Pisa 85
Bern 84
Boulder 82
São Paulo 74
The Dalles 65
Seoul 64
Council Bluffs 59
Falls Church 59
Kunming 58
Columbus 56
Ogden 54
London 53
Shenyang 48
Jüchen 47
Helsinki 46
Redwood City 44
Brussels 42
Jinan 41
Rome 39
Tianjin 38
Changsha 36
Vienna 36
Hebei 35
Turku 34
Fuzhou 33
Washington 33
Belo Horizonte 30
Pune 30
Tokyo 30
Dallas 29
Dakar 27
Norwalk 27
Saint Petersburg 27
Rio de Janeiro 26
Hangzhou 25
Nuremberg 25
Auburn Hills 23
Jiaxing 22
Nürnberg 22
Tashkent 22
San Francisco 21
Brasília 20
Hyderabad 20
Phoenix 19
Chicago 17
Düsseldorf 17
Marseille 17
Toronto 17
Cotonou 16
Curitiba 16
Warsaw 16
Brooklyn 15
Lahore 14
New Delhi 14
Orange 14
Salt Lake City 14
Amsterdam 13
Changchun 13
Lagos 13
Lucca 13
Baghdad 12
Totale 24.429
Nome #
Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta-Analysis 347
Identification of a cytochrome P450-2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients 301
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 247
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 210
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 200
Cigarette Smoking and Hypertension 193
Aging and hypertension. What about the endothelium? 189
Endothelial dysfunction in hypertension: Pathophysiological mechanism or marker of cardiovascular risk? 189
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome 187
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. 181
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 176
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 170
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 170
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. 169
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 169
Obesity in the childhood: a link to adult hypertension 169
Spironolactone improves angiotensin-induced vascular changes and oxidative stress 167
Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy 166
Device-based therapies for resistant hypertension. 166
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma 161
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 161
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 159
Adenosine causes angiotensin II release in human forearm arterioles. 159
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 158
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 158
Adenosine and the vascular tissue renin-angiotensin system in the forearm of essential hypertensive patients 157
Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. 157
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients 157
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension 157
Low birth weight and insulin resistance: can capillary recruitment predict hypertension development? 152
Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats 152
Menopause is associated with endothelial dysfunction in women 152
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 152
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 151
Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes 151
Vascular inflammation: a role in vascular disease in hypertension? 150
Adenosine activates a vascular renin-angiotensin system in hypertensive subjects. 150
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension 150
Hypertension causes premature aging of endothelial function in humans 150
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. 149
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 149
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 146
Antihypertensive drugs and reversing of endothelial dysfunction in hypertension 146
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 146
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 145
Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension. Hypertension 143
Cutaneous vasodilation to acetylcholine in patients with essential hypertension 143
Endothelial function in hypertension 143
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 142
Blood pressure and vascular alterations with growth in childhood. 142
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. 142
Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. 142
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 141
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients 141
Microvascular endothelial dysfunction in obesity and hypertension. 141
Ventricular and vascular stiffening in aging and hypertension 141
ROLE OF NAD(P)H OXIDASE ON VASCULAR ALTERATIONS IN ANGIOTENSIN II-INFUSED MICE 140
Vascular dysfunction in a mouse model of rett syndrome and effects of curcumin treatment. 140
Microvascular Endothelial Dysfunction in Patients with Obesity 140
Vascular renin-angiotensin system and sympathetic nervous system activity in human hypertension. 139
Endothelial function in hypertension. Evidences in humans. 138
Hypertension and cardiometabolic risk factors. 138
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 137
Forearm vasodilation to acetylcholine is increased by potassium in essential hypertensive patients 136
Systemic inflammation and endothelial dysfunction in patients with Hashimoto’s thyroiditis and subclinical hypothyroidism 136
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension 136
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 136
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients 136
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis 135
Vascular reactivity in patients with undifferentiated connective tissue diseases 135
Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. 135
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II 135
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 135
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction 134
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women 134
null 134
Human endothelial dysfunction: EDCFs 133
Hypertension and Atrial Fibrillation: any Change with the New Anticoagulants. 133
Effect of potassium on vasodilation to acetylcholine in essential hypertension. 132
Central blood pressure, arterial stiffness, and wave reflection: New targets of treatment in essential hypertension 132
Endothelial dysfunction as a target for prevention of cardiovascular disease 132
Age- and Sex-Specific Reference Values for Media/Lumen Ratio in Small Arteries and Relationship With Risk Factors 132
Vasodilation to acetylcholine in primary and secondary forms of human hypertension. 131
Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy 131
Human Ghrelin: A Gastric Hormone with Cardiovascular Properties 131
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 130
Endothelial function assessment in complicated hypertension 130
Hypertension in the elderly: an evidence-based review. 130
Target organ damage in hypertension 130
Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase. 130
Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients 129
Endothelial dysfunction and vascular disease in later life 129
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy 127
Aging and endothelial function in normotensive subjects and essential hypertensive patients 126
Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjects 126
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis 126
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 126
Soluble E-selectin in essential hypertension: a correlate of vascular structural changes 125
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 125
C-Reactive Protein and Hypertension: is there a causal relationship? 125
Totale 15.132
Categoria #
all - tutte 96.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.881 165 110 127 101 203 89 109 191 190 184 99 313
2021/20222.927 55 181 55 176 532 401 102 185 131 144 143 822
2022/20233.159 386 330 206 280 341 442 14 266 593 37 223 41
2023/20242.342 231 228 280 142 346 468 107 58 52 47 88 295
2024/20258.889 60 348 145 446 700 926 781 537 886 1.224 1.066 1.770
2025/2026247 247 0 0 0 0 0 0 0 0 0 0 0
Totale 32.602